サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1637658

アジア太平洋のオピオイド市場予測（～2030年）・地域別分析：製品別、用途別、投与経路別、流通チャネル別

Asia Pacific Opioids Market Forecast to 2030 - Regional Analysis - by Product, Application, Route of Administration, and Distribution Channel

出版日
ページ情報
英文 93 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
アジア太平洋のオピオイド市場予測（～2030年）・地域別分析：製品別、用途別、投与経路別、流通チャネル別
出版日: 2024年11月22日
発行: The Insight Partners
ページ情報: 英文 93 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋のオピオイド市場は、2022年に24億624万米ドルと評価され、2030年には30億9,177万米ドルに達すると予測され、2022年から2030年までのCAGRは3.2%と推定されます。

慢性疼痛の急増がアジア太平洋のオピオイド市場を押し上げる

心血管疾患、がん、筋骨格系疾患、神経血管疾患などの慢性疾患は、免疫力を低下させることで人の健康に重大な影響を与えます。さらに、これらの疾患を患う患者の多くは、慢性的な痛みを経験しています。上記のような疾患は、成人や高齢者に多く見られます。しかし、これらの病気は子供にも増えています。慢性疼痛は、スポーツ選手やアスリート、過去に怪我をした人にもよく見られます。NCBI（i.e.国立生物工学情報センター）に掲載された研究によると、世界中で成人の20％が痛みに苦しんでおり、年間10％が新たに慢性疼痛と診断されています。痛みは、性別、人種／民族、収入、年齢、地域に関係なく、すべての人々に影響を及ぼすが、世界中に均等に分布しているわけではないです。ヒドロコドン、オキシコドン、モルヒネなどの処方オピオイドは、強力な鎮痛薬であり、怪我や手術、がんや関節炎などの健康状態による痛みの治療に使用されます。

オピオイド処方の増加は、代替疼痛治療よりもオピオイドを奨励する保険償還プログラム、より効率的な治療を奨励するコスト構造、患者の満足度と効果的な疼痛管理を組み合わせた評価などに起因しています。そのため、疼痛管理におけるオピオイドの優位性により、慢性疾患患者の間で需要が高まっています。

アジア太平洋のオピオイド市場概要

中国では、末期疾患に苦しむ高齢者人口が増加しており、オピオイドの需要が大幅に増加すると推定されています。世界保健機関（WHO）によると、同国は最も急速に高齢化人口が増加している国の一つです。同出典によると、2019年の60歳以上の高齢者は2億5,400万人、65歳以上の高齢者は1億7,600万人です。また、平均寿命の伸びと出生率の低下により、2040年までに中国の人口の～28％（4億200万人）が60歳以上になると予想されています。高齢者人口は、関節炎、腰痛、がんなど、痛みを伴う慢性的な健康状態を経験する可能性が高いです。このような場合、高齢者の慢性疼痛管理にオピオイドが使用され、中国のアジア太平洋オピオイド市場の成長に大きな影響を与えます。中国では、重度の病的痛みに苦しむ新たながん患者の数が大幅に増加しています。2020年に発表された研究「Impact of Continuing Medical Education for Physicians on the Quality of Cancer Pain Treatment in China」によると、中国政府は中等度から重度のがん性疼痛の治療にオピオイド鎮痛薬の使用を奨励しており、全国の三次病院や二次病院で広く使用されています。オピオイドは3段階の鎮痛ラダーの主要な部分であり、中等度から重度のがん性疼痛の緩和に推奨されているため、こうした病状や関連治療に関する認識を高めることで、がん性疼痛の治療計画を改善することができます。

アジア太平洋のオピオイド市場の収益と2030年までの予測

アジア太平洋のオピオイド市場のセグメンテーション

アジア太平洋のオピオイド市場は、製品、用途、投与経路、流通チャネル、国に分類されます。

製品別に見ると、アジア太平洋のオピオイド市場は、即放性短時間作用型オピオイドと徐放性長時間作用型オピオイドに区分されます。2022年の市場シェアは、速放性短時間作用型オピオイドセグメントが大きいです。即放性短時間作用型オピオイドはさらにオキシコドン、ヒドロコドン、トラマドール、コデイン、プロポキシフェン、その他に細分化されます。徐放性長時間作用型オピオイドは、さらにオキシコドン、フェンタニル、モルヒネ、メタドン、その他に細分化されます。

用途別では、アジア太平洋オピオイド市場は疼痛管理、麻酔、下痢抑制、咳抑制、脱中毒、その他に分類されます。2022年には疼痛管理分野が最大の市場シェアを占めました。

投与経路別では、アジア太平洋オピオイド市場は経口剤、注射剤、経皮パッチ剤に区分されます。2022年には経口剤が最大の市場シェアを占めています。

流通チャネル別では、アジア太平洋地域のオピオイド市場は病院薬局と小売薬局に二分されます。2022年には病院薬局セグメントがより大きな市場シェアを占めました。

国別では、アジア太平洋オピオイド市場は中国、日本、インド、韓国、オーストラリア、その他アジア太平洋地域に区分されます。2022年のアジア太平洋オピオイド市場シェアは中国が独占しました。

Endo International plc、Mallinckrodt Plc、Neuraxpharm Pharmaceuticals SL、Mayne Pharma Group Ltd、Rusan Pharma Ltd、Teva Pharmaceutical Industries Ltdは、アジア太平洋オピオイド市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋オピオイド市場：主要市場力学

  • 市場促進要因
    • 慢性疼痛の急増
    • 高齢者人口の増加
  • 市場抑制要因
    • 薬物乱用の増加
  • 市場機会
    • 市場企業の戦略的取り組み
  • 促進要因と抑制要因の影響

第5章 オピオイド市場：アジア太平洋の分析

  • アジア太平洋地域のオピオイド市場概要
  • アジア太平洋地域のオピオイド市場収益、2020年～2030年
  • アジア太平洋地域のオピオイド市場予測分析

第6章 アジア太平洋のオピオイド市場分析：製品別

  • 即時放出短時間作用型オピオイド
  • 徐放性長時間作用型オピオイド

第7章 アジア太平洋のオピオイド市場分析：用途別

  • 疼痛管理
  • 麻酔薬
  • 下痢抑制
  • 咳止め
  • 脱中毒
  • その他

第8章 アジア太平洋地域のオピオイド市場分析：投与経路別

  • 経口剤
  • 注射剤
  • 経皮パッチ

第9章 アジア太平洋地域のオピオイド市場分析：流通チャネル別

  • 病院薬局
  • 小売薬局

第10章 アジア太平洋地域のオピオイド市場：国別分析

  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • その他アジア太平洋

第11章 業界情勢

  • オピオイド市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略
    • 成長戦略

第12章 企業プロファイル

  • Endo International plc
  • Mallinckrodt Plc
  • Neuraxpharm Pharmaceuticals SL
  • Mayne Pharma Group Ltd
  • Rusan Pharma Ltd
  • Teva Pharmaceutical Industries Ltd

第13章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Opioids Market Segmentation
  • Table 2. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 4. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 5. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 6. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 7. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 8. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 9. Asia Pacific: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
  • Table 10. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 11. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 12. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 13. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 14. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 15. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 16. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 17. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 18. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 19. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 20. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 21. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 22. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 23. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 24. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 25. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 26. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 27. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 28. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 29. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 30. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 31. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 32. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 33. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 34. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 35. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 36. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 37. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 38. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 39. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 40. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 41. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • Table 42. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
  • Table 43. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 44. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
  • Table 45. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 46. Recent Organic Growth Strategies in Opioids Market
  • Table 47. Recent Inorganic Growth Strategies in the Opioids Market
  • Table 48. Glossary of Terms, Opioids Market

List Of Figures

  • Figure 1. Asia Pacific Opioids Market Segmentation, by Country
  • Figure 2. Asia Pacific Opioids Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Opioids Market Revenue (US$ Million), 2020-2030
  • Figure 5. Asia Pacific Opioids Market Share (%) - by Product (2022 and 2030)
  • Figure 6. Immediate Release Short Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Extended Release Long-Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Asia Pacific Opioids Market Share (%) - by Application (2022 and 2030)
  • Figure 9. Pain Management: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Anesthesia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Diarrhea Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Cough Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. De-Addiction: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Asia Pacific Opioids Market Share (%) - by Route of Administration (2022 and 2030)
  • Figure 16. Oral: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Injectable: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Transdermal Patch: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Asia Pacific Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
  • Figure 20. Hospital Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Retail Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Asia Pacific: Opioids Market, by Key Countries - Revenue (2022) (US$ Million)
  • Figure 23. Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 24. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Growth Strategies in Opioids Market
目次
Product Code: BMIRE00030983

The Asia Pacific opioids market was valued at US$ 2,406.24 million in 2022 and is expected to reach US$ 3,091.77 million by 2030; it is estimated to register a CAGR of 3.2% from 2022 to 2030.

Surging Chronic Pain Incidence Boosts Asia Pacific Opioids Market

Chronic diseases such as cardiovascular disease, cancer, musculoskeletal diseases, and neurovascular diseases critically affect a person's health by lowering immunity. Moreover, many patients suffering from these conditions experiences chronic pain. The diseases mentioned above are most common in adults and the geriatric population. Nevertheless, cases of these diseases are noticeably growing among children as well. Chronic pain is also common among sportspersons, athletes, and individuals living with past injuries. According to a study published in the NCBI (i.e., National Center for Biotechnology Information), 20% of adults suffer from pain worldwide, and 10% are newly diagnosed with chronic pain per year. While pain affects all populations, regardless of sex, race/ethnicity, income, age, or geography, it is not distributed equally across the world. Prescription opioids, including hydrocodone, oxycodone, and morphine, are potent pain-reducing medications that are used to treat pain caused by injuries, surgeries, and health conditions such as cancer and arthritis.

Increased opioid prescribing practices can be attributed to the insurance reimbursement programs that incentivize opioids over alternative pain treatments, cost structures that encourage more efficient care, and evaluations that combine patient satisfaction with effective pain management. Therefore, owing to the advantage of opioids in pain management, the demand is rising among patients with chronic diseases.

Asia Pacific Opioids Market Overview

The growing geriatric population in China suffering from terminal illnesses is estimated to significantly increase the demand for opioids. As per the World Health Organization (WHO), the country has one of the fastest-growing aging populations. Per the same source, 254 million people were aged 60 and above in 2019 and 176 million people were aged 65 and above. Also, ~28% of the population (402 million people) in China is expected to be aged 60 and above by 2040 due to increasing life expectancy and decreasing birth rates. Geriatric populations are more likely to experience chronic health conditions that are associated with pain, such as arthritis, back pain, cancer, etc. In such cases, opioids are used to manage chronic pain in older adults, which significantly influence the growth of the Asia Pacific opioids market in China. In China, the number of new cancer patients suffering from severe pathological pain has significantly increased. As per a study, "Impact of Continuing Medical Education for Physicians on the Quality of Cancer Pain Treatment in China," published in 2020, the government of China encourages the use of opioid analgesics for the treatment of moderate to severe cancer pain, which is widely available in tertiary hospitals and secondary hospitals across the country. As opioids are a major part of a three-step analgesic ladder and are recommended for relieving moderate and severe cancer pain, increasing awareness regarding such medical conditions and associated treatment can improve the treatment plan for cancer pain.

Asia Pacific Opioids Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Opioids Market Segmentation

The Asia Pacific opioids market is categorized into product, application, route of administration, distribution channel, and country.

Based on product, the Asia Pacific opioids market is segmented immediate release short acting opioid and extended release long acting opioid. The immediate release short acting opioid segment held a larger market share in 2022. The immediate release short acting opioid is further sub segmented into oxycodone, hydrocodone, tramadol, codeine, propoxyphene, and others. The extended release long acting opioid is further sub segmented into oxycodone, fentanyl, morphine, methadone, and others.

In terms of application, the Asia Pacific opioids market is categorized into pain management, anesthesia, diarrhea suppression, cough suppression, de-addiction, and others. The pain management segment held the largest market share in 2022.

By route of administration, the Asia Pacific opioids market is segmented into oral, injectable, and transdermal patch. The oral segment held the largest market share in 2022.

By distribution channel, the Asia Pacific opioids market is bifurcated into hospital pharmacies and retail pharmacies. The hospital pharmacies segment held a larger market share in 2022.

By country, the Asia Pacific opioids market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific opioids market share in 2022.

Endo International plc, Mallinckrodt Plc, Neuraxpharm Pharmaceuticals SL, Mayne Pharma Group Ltd, Rusan Pharma Ltd, and Teva Pharmaceutical Industries Ltd are some of the leading companies operating in the Asia Pacific opioids market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Opioids Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Surging Chronic Pain Incidence
    • 4.1.2 Increasing Geriatric Population
  • 4.2 Market Restraints
    • 4.2.1 Increasing Drug Abuse
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives by Market Players
  • 4.4 Impact of Drivers and Restraints:

5. Opioids Market - Asia Pacific Analysis

  • 5.1 Asia Pacific Opioids Market Overview
  • 5.2 Asia Pacific Opioids Market Revenue (US$ Million), 2020-2030
  • 5.3 Asia Pacific Opioids Market Forecast Analysis

6. Asia Pacific Opioids Market Analysis - by Product

  • 6.1 Immediate Release Short Acting Opioid
    • 6.1.1 Overview
    • 6.1.2 Immediate Release Short Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.1.2.1 Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
  • 6.2 Extended Release Long-Acting Opioid
    • 6.2.1 Overview
    • 6.2.2 Extended Release Long-Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.2.2.1 Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid

7. Asia Pacific Opioids Market Analysis - by Application

  • 7.1 Pain Management
    • 7.1.1 Overview
    • 7.1.2 Pain Management: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Anesthesia
    • 7.2.1 Overview
    • 7.2.2 Anesthesia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Diarrhea Suppression
    • 7.3.1 Overview
    • 7.3.2 Diarrhea Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Cough Suppression
    • 7.4.1 Overview
    • 7.4.2 Cough Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 De-Addiction
    • 7.5.1 Overview
    • 7.5.2 De-Addiction: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Opioids Market Analysis - by Route of Administration

  • 8.1 Oral
    • 8.1.1 Overview
    • 8.1.2 Oral: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Injectable
    • 8.2.1 Overview
    • 8.2.2 Injectable: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Transdermal Patch
    • 8.3.1 Overview
    • 8.3.2 Transdermal Patch: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Opioids Market Analysis - by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Overview
    • 9.1.2 Hospital Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Retail Pharmacies
    • 9.2.1 Overview
    • 9.2.2 Retail Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Opioids Market - Country Analysis

  • 10.1 Asia Pacific
    • 10.1.1 Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
      • 10.1.1.1 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 China: Asia Pacific Opioids Market Breakdown, by Product
        • 10.1.1.2.2 China: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 10.1.1.2.3 China: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 10.1.1.2.4 China: Asia Pacific Opioids Market Breakdown, by Application
        • 10.1.1.2.5 China: Asia Pacific Opioids Market Breakdown, by Route of Administration
        • 10.1.1.2.6 China: Asia Pacific Opioids Market Breakdown, by Distribution Channel
      • 10.1.1.3 Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Japan: Asia Pacific Opioids Market Breakdown, by Product
        • 10.1.1.3.2 Japan: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 10.1.1.3.3 Japan: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 10.1.1.3.4 Japan: Asia Pacific Opioids Market Breakdown, by Application
        • 10.1.1.3.5 Japan: Asia Pacific Opioids Market Breakdown, by Route of Administration
        • 10.1.1.3.6 Japan: Asia Pacific Opioids Market Breakdown, by Distribution Channel
      • 10.1.1.4 India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 India: Asia Pacific Opioids Market Breakdown, by Product
        • 10.1.1.4.2 India: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 10.1.1.4.3 India: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 10.1.1.4.4 India: Asia Pacific Opioids Market Breakdown, by Application
        • 10.1.1.4.5 India: Asia Pacific Opioids Market Breakdown, by Route of Administration
        • 10.1.1.4.6 India: Asia Pacific Opioids Market Breakdown, by Distribution Channel
      • 10.1.1.5 South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.1 South Korea: Asia Pacific Opioids Market Breakdown, by Product
        • 10.1.1.5.2 South Korea: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 10.1.1.5.3 South Korea: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 10.1.1.5.4 South Korea: Asia Pacific Opioids Market Breakdown, by Application
        • 10.1.1.5.5 South Korea: Asia Pacific Opioids Market Breakdown, by Route of Administration
        • 10.1.1.5.6 South Korea: Asia Pacific Opioids Market Breakdown, by Distribution Channel
      • 10.1.1.6 Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Australia: Asia Pacific Opioids Market Breakdown, by Product
        • 10.1.1.6.2 Australia: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 10.1.1.6.3 Australia: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 10.1.1.6.4 Australia: Asia Pacific Opioids Market Breakdown, by Application
        • 10.1.1.6.5 Australia: Asia Pacific Opioids Market Breakdown, by Route of Administration
        • 10.1.1.6.6 Australia: Asia Pacific Opioids Market Breakdown, by Distribution Channel
      • 10.1.1.7 Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.7.1 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Product
        • 10.1.1.7.2 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
        • 10.1.1.7.3 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
        • 10.1.1.7.4 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Application
        • 10.1.1.7.5 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Route of Administration
        • 10.1.1.7.6 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Distribution Channel

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Opioids Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Endo International plc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Mallinckrodt Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Neuraxpharm Pharmaceuticals SL
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Mayne Pharma Group Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Rusan Pharma Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Teva Pharmaceutical Industries Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms